If you have less than a minute:
- Cases are dropping thanks to vaccines, real-world data shows.
- The US lifted pause on J&J vaccine as blood clotting cases remained small.
- UK economy is bouncing back strongly as restrictions ease.
- One dose of AstraZeneca or Pfizer's vaccine provides protection against COVID-19 that lasts at least 10 weeks. A single shot reduced infections by 65% in a UK survey of about 275,000 people, and effectiveness rose to 72% against COVID-19 with symptoms. Another research shows that the one-shot vaccine cuts infection risk in all age groups.
- The number of rare blood clotting disorders in recipients of the Johnson & Johnson vaccine has remained small. Thus, US Federal health officials lifted their temporary pause on the use of Johnson & Johnson’s coronavirus vaccine.
- Research shows a growing number of findings suggesting Pfizer and Moderna vaccines are effective against the New York variant.
- Reinfection is possible but rare, data from 63 million medical records shows. Out of about 400,000 people with positive tests for the coronavirus, only 0.4 percent tested positive twice in a period more than 90 days apart, according to the study by health-care software company Epic Systems.
- In addition to vaccines, Here is a summary of some of the drugs that have been found to help in the pandemic so far.
- Surveillance indicators suggest that at a national level COVID-19 activity decreased in week 15 of 2021. Case rates have fallen across all age groups. The hospital admission rate for COVID-19 has fallen – it was 1.52 per 100,000 in week 15, compared to 1.88 per 100,000 in the previous week.
- The economy is bouncing back strongly from its Covid-19-induced recession as restrictions ease, shoppers return to high streets, and outdoor diners pack back into pubs and restaurants.
- In Scotland, First Minister Nicola Sturgeon has announced details of significant easing of restrictions across retail, hospitality, and travel.
- Covid-19 rates in Los Angeles have gone from worst to among the best. Researchers’ main theory for explaining such turnaround (despite vaccination rates lower than the US average) includes high immunity caused by previous spikes and a common variant in California that may be keeping out more infectious strains.
- South Africa decides to resume use of Johnson & Johnson vaccines.
- France lays out a reopening timeline as vaccinations pick up speed
- Taiwan is in talks over travel bubbles with Singapore, Philippines, Vietnam, and Guam.
- The Johnson & Johnson's vaccines are expected to be imported to India by June-July 2021. Johnson & Johnson's is working closely with Biological E to facilitate the ongoing tech transfer to India. For now, International efforts are under way to help India as the country faces critical oxygen shortages amid a record covid surge.